Cargando…
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: In some patients, acute, life-threatening respiratory injury produced by viruses such as SARS-CoV and other viral pneumonia are associated with an over-exuberant cytokine release. Elevated levels of blood IL-6 had been identified as a one of the risk factors associated with severe COVID-...
Autores principales: | Caballero Bermejo, Antonio F., Ruiz-Antorán, Belén, Fernández Cruz, Ana, Diago Sempere, Elena, Callejas Díaz, Alejandro, Múñez Rubio, Elena, Avendaño-Solá, Cristina, Ramos Martínez, Antonio, Sancho López, Aránzazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492787/ https://www.ncbi.nlm.nih.gov/pubmed/32938496 http://dx.doi.org/10.1186/s13063-020-04633-3 |
Ejemplares similares
-
Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
por: Sancho-López, Aránzazu, et al.
Publicado: (2021) -
Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm
por: Darnaude-Ximénez, Ignacio, et al.
Publicado: (2022) -
Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
por: Diago-Sempere, Elena, et al.
Publicado: (2021) -
Bronchopulmonary penetration of isavuconazole in lung transplant recipients
por: Caballero-Bermejo, Antonio F., et al.
Publicado: (2023) -
Sartre /
por: Nuño Montes, Juan Antonio
Publicado: (1971)